Literature DB >> 3895396

Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.

T E Mollnes.   

Abstract

A double-antibody biotin-avidin enzyme-linked immunosorbent assay (ELISA) for quantification of the C3d split products is described. Polyethylene glycol 6000 was used to precipitate large C3 molecules, and the C3d-containing supernatant was used in the assay. C3d was measured in ethylenediaminetetraacetic acid plasma from 40 healthy blood donors, and the normal range was defined. Twenty-two patients were tested, and 12 of these had increased levels of C3d. No correlation was observed between total C3 and C3d in these patients. There was a close correlation between C3d measured by this method and by the double-decker rocket immunoelectrophoresis method. The C3d ELISA method is very sensitive, easy to perform, and time-saving and economical compared with most C3d methods already described. A procedure to define the lower detection limit and examine the reliability of an ELISA method in general is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895396     DOI: 10.1111/j.1365-3083.1985.tb01851.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

Review 1.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

2.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.

Authors:  T E Mollnes; Y C Ng; D K Peters; T Lea; J Tschopp; M Harboe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

4.  Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.

Authors:  J Freysdottir; S Ormarsdottir; A Sigfusson
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

5.  Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation.

Authors:  J Jones; B P Morgan
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

6.  Measurement of terminal complement complexes in rheumatoid arthritis.

Authors:  B P Morgan; R H Daniels; B D Williams
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.